Incyte (INCY) PT Lowered to $101 at BofA Securities
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $121.07 -0.39%
Rating Summary:
17 Buy, 17 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
17 Buy, 17 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Incyte (NASDAQ: INCY) to $101.00 (from $102.00) while maintaining a Buy rating.
You May Also Be Interested In
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at BTIG
- Bicara Therapeutics Inc (BCAX) PT Raised to $39 at Morgan Stanley
- SandRidge Energy (SD) PT Lowered to $14 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
